Cited by 172Telomeres, Telomerase, and SenescenceRheumatoid Arthritis Research and TherapiesT-cell and B-cell Immunology

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Telomerase insufficiency in rheumatoid arthritis

Open access
Fujii, Hiroshi, Shao, Lan, Colmegna, Inés, Goronzy, Jörg J., Weyand, Cornelia M.·2009·Proceedings of the National Academy of Sciences

Abstract

In rheumatoid arthritis (RA), chronically stimulated T lymphocytes sustain tissue-destructive joint inflammation. Both naïve and memory T cells in RA are prematurely aged with accelerated loss of telomeres suggesting excessive proliferative pressure or inadequate telomeric maintenance. Upon stimulation, RA naïve CD4 T cells are defective in up-regulating telomerase activity ( P < 0.0001) due to insufficient induction of the telomerase component human telomerase reverse transcriptase (hTERT); T cell activation and cell cycle progression are intact. Telomerase insufficiency does not affect memory T cells or CD34 hematopoietic stem cells and is present in untreated patients and independent from disease activity. Knockdown of hTERT in primary human T cells increases apoptotic propensity ( P = 0.00005) and limits clonal burst ( P = 0.0001) revealing a direct involvement of telomerase in T cell fate decisions. Naïve RA CD4 T cells stimulated through the T cell receptor are highly susceptible to apoptosis, expanding to smaller clonal size. Overexpression of ectopic hTERT in naïve RA T cells conveys apoptotic resistance ( P = 0.008) and restores proliferative expansion ( P < 0.0001). Telomerase insufficiency in RA results in excessive T cell loss, undermining homeostatic control of the naive T cell compartment and setting the stage for lymphopenia-induced T cell repertoire remodeling. Restoring defective telomerase activity emerges as a therapeutic target in resetting immune abnormalities in RA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0811332106

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

Sorted by citations

Items 101–172 of 172

Metadata

Authors
Fujii, H., Shao, L., Colmegna, I., Goronzy, J. J., & Weyand, C. M.
Affiliations
Emory University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2009-03-17
Volume
106
Issue
11
Pages
4360-4365
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2067557887
Cited by
172
References
45
Citations by year
2026: 2 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 16 · 2019: 15 · 2018: 11 · 2017: 10 · 2016: 9 · 2015: 11 · 2014: 8 · 2013: 13 · 2012: 11
FWCI
8.39
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000454)
  • National Institute on Aging (R01AG015043, R01AG15043)
  • National Heart, Lung, and Blood Institute (R01HL117913)
  • National Eye Institute (R01EY011916)
  • National Institute of Allergy and Infectious Diseases (R01AI044142, R01 AI57266, R01AI44142, R01AI108906, R56AI044142, U19AI057266)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041974, R01 AR 41974, R01AR042527, R01AR42527)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
rheumatoid arthritis, human telomerase reverse transcriptase, hTERT, T cell senescence, naive CD4+ T cells, memory T cells, T cell apoptosis, clonal expansion, lymphopenia, T cell receptor stimulation, hematopoietic stem cells, joint inflammation, telomere length
MeSH terms
Arthritis, Rheumatoid, Hematopoietic Stem Cells, Humans, Immunologic Memory, T-Lymphocytes, Down-Regulation, Case-Control Studies, Telomere, Cellular Senescence, Telomerase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review